Literature DB >> 29871793

Antimüllerian hormone as a risk factor for miscarriage in naturally conceived pregnancies.

Brianna M Lyttle Schumacher1, Anne Marie Z Jukic2, Anne Z Steiner3.   

Abstract

OBJECTIVE: To determine the association between antimüllerian hormone (AMH), a measure of ovarian reserve, and miscarriage among naturally conceived pregnancies.
DESIGN: Prospective cohort study.
SETTING: Not applicable. PATIENT(S): Women (n = 533), between 30 and 44 years of age with no known history of infertility, polycystic ovarian syndrome, or endometriosis who conceived naturally. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Miscarriage, defined as an intrauterine pregnancy loss before 20 weeks' gestation. RESULT(S): After adjusting for maternal age, race, history of recurrent miscarriage, and obesity, risk of miscarriage decreased as AMH increased (risk ratio per unit increase in natural log of AMH = 0.83; 95% confidence interval [CI], 0.73, 0.94). Women with severely diminished ovarian reserve (AMH ≤ 0.4 ng/mL) miscarried at over twice the rate of women with an AMH ≥ 1 ng/mL (hazard ratio, 2.3; 95% CI, 1.3, 4.3). CONCLUSION(S): AMH levels are inversely associated with the risk of miscarriage. Women with severely diminished ovarian reserve are at an increased risk of miscarriage.
Copyright © 2018 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antimüllerian hormone; diminished ovarian reserve; miscarriage; pregnancy loss

Mesh:

Substances:

Year:  2018        PMID: 29871793      PMCID: PMC6063511          DOI: 10.1016/j.fertnstert.2018.01.039

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  26 in total

1.  Is ABO blood type associated with ovarian stimulation response in patients with diminished ovarian reserve?

Authors:  Nigel Pereira; Anne P Hutchinson; Jennifer L Bender; Jovana P Lekovich; Rony T Elias; Zev Rosenwaks; Steven D Spandorfer
Journal:  J Assist Reprod Genet       Date:  2015-05-03       Impact factor: 3.412

2.  The relationship between anti-Müllerian hormone in women receiving fertility assessments and age at menopause in subfertile women: evidence from large population studies.

Authors:  M Dólleman; M J Faddy; J van Disseldorp; Y T van der Schouw; C M Messow; B Leader; P H M Peeters; A McConnachie; S M Nelson; F J M Broekmans
Journal:  J Clin Endocrinol Metab       Date:  2013-03-18       Impact factor: 5.958

3.  Correlation of ovarian reserve tests with histologically determined primordial follicle number.

Authors:  Karl R Hansen; George M Hodnett; Nicholas Knowlton; LaTasha B Craig
Journal:  Fertil Steril       Date:  2010-06-01       Impact factor: 7.329

4.  Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women.

Authors:  S L Broer; M J C Eijkemans; G J Scheffer; I A J van Rooij; A de Vet; A P N Themmen; J S E Laven; F H de Jong; E R Te Velde; B C Fauser; F J M Broekmans
Journal:  J Clin Endocrinol Metab       Date:  2011-05-25       Impact factor: 5.958

5.  Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.

Authors:  Didier Dewailly; Pascal Pigny; Benoît Soudan; Sophie Catteau-Jonard; Christine Decanter; Edouard Poncelet; Alain Duhamel
Journal:  J Clin Endocrinol Metab       Date:  2010-07-07       Impact factor: 5.958

Review 6.  Obesity and female infertility: potential mediators of obesity's impact.

Authors:  Darcy E Broughton; Kelle H Moley
Journal:  Fertil Steril       Date:  2017-03-11       Impact factor: 7.329

7.  Do women with unexplained recurrent pregnancy loss have higher day 3 serum FSH and estradiol values?

Authors:  S W Trout; D B Seifer
Journal:  Fertil Steril       Date:  2000-08       Impact factor: 7.329

8.  Impact of female age and nulligravidity on fecundity in an older reproductive age cohort.

Authors:  Anne Z Steiner; Anne Marie Z Jukic
Journal:  Fertil Steril       Date:  2016-03-05       Impact factor: 7.329

9.  Is Anti-Müllerian Hormone Associated With Fecundability? Findings From the EAGeR Trial.

Authors:  Shvetha M Zarek; Emily M Mitchell; Lindsey A Sjaarda; Sunni L Mumford; Robert M Silver; Joseph B Stanford; Noya Galai; Mark V White; Karen C Schliep; Alan H DeCherney; Enrique F Schisterman
Journal:  J Clin Endocrinol Metab       Date:  2015-09-25       Impact factor: 5.958

10.  Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH.

Authors:  Norbert Gleicher; Vitaly A Kushnir; Aritro Sen; Sarah K Darmon; Andrea Weghofer; Yan-Guang Wu; Qi Wang; Lin Zhang; David F Albertini; David H Barad
Journal:  J Transl Med       Date:  2016-06-10       Impact factor: 5.531

View more
  12 in total

1.  Chemotherapy-related damage to ovarian reserve in childhood cancer survivors: interpreting the evidence.

Authors:  Edgardo Somigliana; Monica Terenziani; Francesca Filippi; Alice Bergamini; Fabio Martinelli; Giorgia Mangili; Fedro Peccatori; Paolo Vercellini
Journal:  J Assist Reprod Genet       Date:  2018-10-25       Impact factor: 3.412

2.  Diminished ovarian reserve in young women with sickle cell anemia.

Authors:  Lydia H Pecker; Sarah Hussain; Jaanvi Mahesh; Ravi Varadhan; Mindy S Christianson; Sophie Lanzkron
Journal:  Blood       Date:  2022-02-17       Impact factor: 22.113

3.  Anti-Müllerian hormone in guiding the selection of a freeze-all versus a fresh embryo transfer strategy: a cohort study.

Authors:  Kai-Lun Hu; Rui Yang; Huiyu Xu; Ben W Mol; Rong Li; Rui Wang
Journal:  J Assist Reprod Genet       Date:  2022-07-23       Impact factor: 3.357

4.  Live Birth Rates in Women Under 38 Years Old with AMH Level < 1.2 ng/ml in the First In Vitro Fertilization + / - Intracytoplasmic Sperm Injection: Retrospective Study and Arguments for Care.

Authors:  Karine Morcel; Philippe Merviel; Diane Pertuisel; Pandora James; Sarah Bouée; Mathilde Le Guillou; Jean-Jacques Chabaud; Sylvie Roche; Hortense Drapier; Aurore Perrin; Damien Beauvillard
Journal:  Reprod Sci       Date:  2022-09-29       Impact factor: 2.924

5.  Novel variants in women with premature ovarian function decline identified via whole-exome sequencing.

Authors:  Ruiyi Tang; Qi Yu
Journal:  J Assist Reprod Genet       Date:  2020-08-13       Impact factor: 3.412

6.  Antimullerian hormone is a predictor of live birth in patients with recurrent pregnancy loss.

Authors:  Gayathree Murugappan; Lora Shahine; Ruth B Lathi
Journal:  Fertil Res Pract       Date:  2019-03-15

7.  Age-specific anti-Mullerian hormone (AMH) levels poorly affects cumulative live birth rate after intra-uterine insemination.

Authors:  Jessika Moreau; Nicolas Gatimel; Cynthia Simon; Clémentine Cohade; Florence Lesourd; Jean Parinaud; Roger Léandri
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-05-13

8.  Anti-Mullerian hormone (AMH) test information on Australian and New Zealand fertility clinic websites: a content analysis.

Authors:  Tessa Copp; Brooke Nickel; Sarah Lensen; Karin Hammarberg; Devora Lieberman; Jenny Doust; Ben W Mol; Kirsten McCaffery
Journal:  BMJ Open       Date:  2021-07-07       Impact factor: 2.692

9.  Decision regret and associated factors following oocyte cryopreservation in patients with diminished ovarian reserve and/or age-related fertility decline.

Authors:  Aysen Gurbuz; Aylin Pelin Cil; Lale Suzan Karakis; Remzi Abali; Mehmet Ceyhan; Ece Aksakal; Azer Kilic; Mustafa Bahceci; Bulent Urman
Journal:  J Assist Reprod Genet       Date:  2021-04-02       Impact factor: 3.357

10.  Asthma and/or hay fever as predictors of fertility/impaired fecundity in U.S. women: National Survey of Family Growth.

Authors:  Paul C Turkeltaub; Richard F Lockey; Katie Holmes; Erika Friedmann
Journal:  Sci Rep       Date:  2019-12-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.